GALMED PHARMACEUTICALS LTD. Payments of Stock Issuance Costs
GALMED PHARMACEUTICALS LTD. (GLMD) reported Payments of Stock Issuance Costs of $2.00 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2025-04-02.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2025-04-02
| Period end | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 12 month | Payments of Stock Issuance Costs 12 month as first filed |
|---|---|---|---|
| 2022-12-31 | $2.00K 20-F · filed 2025-04-02 | ||
| 2017-06-30 | $0.00 6-K · filed 2017-07-31 | ||
| 2016-06-30 | $143.00K 6-K · filed 2017-07-31 | ||
| 2015-06-30 | $0.00 6-K · filed 2017-06-23 | ||
| 2014-12-31 | $4.20M 20-F · filed 2016-03-22 | $4.20K 20-F · filed 2015-03-31 |